Shils Award

Shil's Award

 

Dr. Carolyn Primus Winner of 2016 Dr. Edward B. Shils Award

Bioceramic materials pioneer cited for innovative product development

HOUSTON, TEXAS, November 21, 2016—NuSmile Ltd. today announced that Dr. Carolyn Primus, leader of its research efforts in bioceramic materials, was a recent winner of the 2016 Dr. Edward B. Shils Award. Dr. Primus was the founder and CEO of advanced mineral trioxide aggregate (MTA) manufacturer Avalon Biomed Inc., substantially all of whose assets were recently acquired by NuSmile.

The Dr. Edward B. Shils Award is given to companies, people and organizations that have made an impact on the dental community and oral health. The award is presented by the Dr. Edward B. Shils Entrepreneurial Fund, a nonprofit organization dedicated to innovative leadership in health care. The organization is named after the late Dr. Edward B. Shils, who was the executive director of the Dental Manufacturers of America and the Dental Dealers of America for almost 50 years.

The board of directors presented Dr. Primus with the award based on her “innovation and development of many products for fixed prosthodontics, orthodontics and endodontics to enhance dental procedures and advance the dental profession.”

Dr. Primus has made a profound impact on dentistry through her significant advancements with mineral trioxide aggregate (MTA), which is used in vital pulp therapy and endodontics. Dr. Primus has three patents in this area that have enabled her to invent an MTA product that is easier to use. The company she founded, Avalon Biomed, has also made this bioactive pulp treatment and endodontic treatment more affordable for clinicians so that it can be used with patients for whom treatment with an MTA might not be financially viable. With Avalon Biomed now a part of NuSmile, Dr. Primus is able to continue her bioactive material research that was originally supported by an NIH SBIR grant.

Dr. Primus stated, “I am delighted and honored to receive the Shils Award. Throughout my dental career, inventing useful biomaterials has remained at the forefront of my goals. The Dr. Edward B. Shils Entrepreneurial Fund has provided me further inspiration to continue to innovate for better dental treatments as part of the NuSmile team.”

 

Leave a Reply

Your email address will not be published. Required fields are marked *

NeoMTA Plus is a stainproof, tricalcium silicate-based bioactive cement that can be used universally for vital pulp and other endodontic indications in primary and permanent teeth. NeoMTA Plus is a bioceramic cement that triggers the healing process. With NeoMTA Plus, general dentists, pediatric dentists, and endodontists now have a superior and reasonably priced bioceramic. Dentists praise the multi-use NeoMTA Plus because it mixes more smoothly, is easier to dispense and the unique gel enables more stable placement, washout resistance and faster clinical setting.

New, stain-free light color:

Ideal for pediatric dentistry—won’t discolor teeth
Liquids such as sodium hypochlorite won’t cause discoloration

Multiple indications:

Pulp-capping to base/liner
Pulpotomies to apexification
Sealer to perforation repair
Root-end filling to resorption

Non-cytotoxic

Inhibits bacterial growth* *Tested in vitro. Not a disinfectant

Grey MTA Plus is a bioceramic tricalcium silicate-based Dental Cement, which is slightly more radiopaque than (white) MTA. The light silvery color of MTA Plus is visible during placement. Grey MTA Plus is indicated for both Vital Pulp Therapy and Endodontic procedures. General dentists and endodontists praise the multi-use Grey MTA Plus because it mixes more smoothly and is easier to dispense. The unique gel enables more stable placement, washout resistance and faster clinical setting.

Multiple indications:

Pulp-capping to Base/Liner
Pulpotomies to Apexification
Sealer to Perforation Repair
Root-end Filling to Resorption

New, light grey color:

More radiopaque than the leading white MTAs
Visible for precise placement
Inhibits bacterial growth in vitro of Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Pseudomonas aeruginosa.
Non-cytotoxic

Better mixing, handling and placement:

Finer powder mixes more easily and smoothly
Dispense as little as 0.1 gm
Unique gel for stable placement
Washout resistant
No special equipment required

Smart, convenient packaging:

Protects fine powder in desiccant-lined bottle
Easy to dispense powder as needed
Dropper-tip gel bottle minimizes waste